Eventide Asset Management’s Dynavax Technologies DVAX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-673,810
Closed -$8.6M 231
2024
Q4
$8.6M Hold
673,810
0.16% 135
2024
Q3
$7.51M Sell
673,810
-2,223,777
-77% -$24.5M 0.13% 132
2024
Q2
$32.5M Buy
2,897,587
+634
+0% +$7.38K 0.56% 59
2024
Q1
$36M Buy
2,896,953
+3,518
+0.1% +$45.9K 0.56% 62
2023
Q4
$40.5M Buy
2,893,435
+1,468,435
+103% +$20.4M 0.66% 52
2023
Q3
$21M Buy
1,425,000
+398,914
+39% +$5.61M 0.38% 78
2023
Q2
$13.3M Buy
+1,026,086
New +$11.7M 0.22% 111
2016
Q4
Sell
-250,000
Closed -$2.62M 129
2016
Q3
$2.62M Hold
250,000
0.16% 91
2016
Q2
$3.65M Hold
250,000
0.22% 78
2016
Q1
$4.81M Hold
250,000
0.27% 76
2015
Q4
$6.04M Sell
250,000
-30,700
-11% -$769K 0.3% 78
2015
Q3
$6.89M Buy
280,700
+86,200
+44% +$2.44M 0.4% 62
2015
Q2
$4.56M Buy
194,500
+67,100
+53% +$1.46M 0.25% 76
2015
Q1
$2.86M Buy
+127,400
New +$2.44M 0.22% 88

Other funds holding DVAX

Eventide Asset Management's DVAX Position: Q1 2025 in Review

Eventide Asset Management sold out of Dynavax Technologies (DVAX) in Q1 2025, closing a stake of 673,810 shares — an estimated $8.6M sold.

Eventide Asset Management first reported a position in DVAX in Q1 2015 and held it in 14 quarters. The position peaked at $40.5M in Q4 2023. 284 funds tracked by Wall St. Rank hold DVAX as of Q1 2025.

  • Eventide Asset Management reported no remaining Dynavax Technologies position as of Q1 2025 after selling out during the quarter.
  • Eventide Asset Management sold 673,810 Dynavax Technologies shares in Q1 2025, an estimated $8.6M.
  • Eventide Asset Management first reported a position in Dynavax Technologies in Q1 2015 and held it in 14 quarters.
  • Eventide Asset Management's Dynavax Technologies position peaked at $40.5M in Q4 2023.
  • 284 funds tracked by Wall St. Rank held Dynavax Technologies as of Q1 2025.

Based on Eventide Asset Management's 13F filing for Q1 2025, filed 15 May 2025.